Alyeska Investment Group, L.P. - MEDICENNA THERAPEUTICS CORP ownership

MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 29 filers reported holding MEDICENNA THERAPEUTICS CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of MEDICENNA THERAPEUTICS CORP
ValueSharesWeighting
Q4 2022$297,700
-44.8%
650,0000.0%0.00%
-50.0%
Q3 2022$539,000650,0000.01%
Other shareholders
MEDICENNA THERAPEUTICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,339,983$1,270,0440.60%
Worth Venture Partners, LLC 1,088,938$311,3270.18%
Sigma Planning Corp 634,550$187,1290.01%
Verition Fund Management LLC 555,392$158,7870.00%
Hudson Bay Capital Management LP 1,561,128$446,3260.00%
McKinley Carter Wealth Services, Inc. 79,259$23,3740.00%
Warberg Asset Management LLC 20,000$5,8980.00%
Patriot Financial Group Insurance Agency, LLC 15,000$4,4240.00%
LETKO, BROSSEAU & ASSOCIATES INC 120,000$35,3880.00%
Virtu Financial LLC 12,086$30.00%
View complete list of MEDICENNA THERAPEUTICS CORP shareholders